Illumina Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today ...
But Illumina’s divestment of Grail isn’t the ... Exact Sciences reported on a 6,000-sample study of a multi-cancer test it plans to offer alongside single-cancer screening products such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback